The global market for Allogeneic Stem Cells is estimated at US$1.2 Billion in 2023 and is projected to reach US$2.4 Billion by 2030, growing at a CAGR of 10.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Regenerative Therapy Application segment, which is expected to reach US$1.6 Billion by 2030 with a CAGR of 11.8%. The Drug Discovery & Development Application segment is also set to grow at 9.3% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $304.2 Million in 2023, and China, forecasted to grow at an impressive 14.5% CAGR to reach $572.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Allogeneic Stem Cells Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Allogeneic Stem Cells Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Allogeneic Stem Cells Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Biosolution Co. Ltd., Cynata Therapeutics Ltd., JCR Pharmaceuticals Co. Ltd., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 33 Featured):
- Biosolution Co. Ltd.
- Cynata Therapeutics Ltd.
- JCR Pharmaceuticals Co. Ltd.
- Lineage Cell Therapeutics Inc.
- MEDIPOST Co. Ltd.
- MiMedx Group Inc.
- Osiris Therapeutics Inc.
- Stempeutics Research Pvt. Ltd.
- Takeda Pharmaceutical Co. Ltd.;
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Allogeneic Stem Cells - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 2: World Historic Review for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 3: World 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Regenerative Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 5: World Historic Review for Regenerative Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 6: World 16-Year Perspective for Regenerative Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 8: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 9: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
- Table 10: World Allogeneic Stem Cells Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
UNITED STATES
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 11: USA Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 12: USA Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 13: USA 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
CANADA
- Table 14: Canada Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 15: Canada Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 16: Canada 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
JAPAN
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 17: Japan Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 18: Japan Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 19: Japan 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
CHINA
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 20: China Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 21: China Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 22: China 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
EUROPE
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 23: Europe Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 24: Europe Historic Review for Allogeneic Stem Cells by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 25: Europe 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 26: Europe Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 27: Europe Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 28: Europe 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
FRANCE
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 29: France Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 30: France Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 31: France 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
GERMANY
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 32: Germany Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 33: Germany Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 34: Germany 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
ITALY
- Table 35: Italy Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 36: Italy Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 37: Italy 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 38: UK Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 39: UK Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 40: UK 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
SPAIN
- Table 41: Spain Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 42: Spain Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 43: Spain 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
RUSSIA
- Table 44: Russia Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 45: Russia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 46: Russia 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 47: Rest of Europe Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 48: Rest of Europe Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 49: Rest of Europe 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 50: Asia-Pacific Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 51: Asia-Pacific Historic Review for Allogeneic Stem Cells by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 52: Asia-Pacific 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
- Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 54: Asia-Pacific Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 55: Asia-Pacific 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
AUSTRALIA
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
- Table 56: Australia Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 57: Australia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 58: Australia 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
INDIA
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
- Table 59: India Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 60: India Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 61: India 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
SOUTH KOREA
- Table 62: South Korea Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 63: South Korea Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 64: South Korea 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
- Table 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 66: Rest of Asia-Pacific Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 67: Rest of Asia-Pacific 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
LATIN AMERICA
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
- Table 68: Latin America Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 69: Latin America Historic Review for Allogeneic Stem Cells by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 70: Latin America 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
- Table 71: Latin America Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 72: Latin America Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 73: Latin America 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
ARGENTINA
- Table 74: Argentina Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 75: Argentina Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 76: Argentina 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
BRAZIL
- Table 77: Brazil Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 78: Brazil Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 79: Brazil 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
MEXICO
- Table 80: Mexico Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 81: Mexico Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 82: Mexico 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
- Table 83: Rest of Latin America Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 84: Rest of Latin America Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 85: Rest of Latin America 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
MIDDLE EAST
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
- Table 86: Middle East Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 87: Middle East Historic Review for Allogeneic Stem Cells by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 88: Middle East 16-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
- Table 89: Middle East Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 90: Middle East Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 91: Middle East 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
IRAN
- Table 92: Iran Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 93: Iran Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 94: Iran 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
ISRAEL
- Table 95: Israel Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 96: Israel Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 97: Israel 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
SAUDI ARABIA
- Table 98: Saudi Arabia Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 99: Saudi Arabia Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 100: Saudi Arabia 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
- Table 101: UAE Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 102: UAE Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 103: UAE 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
- Table 104: Rest of Middle East Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 105: Rest of Middle East Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 106: Rest of Middle East 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
AFRICA
- Allogeneic Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
- Table 107: Africa Recent Past, Current & Future Analysis for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 108: Africa Historic Review for Allogeneic Stem Cells by Application - Regenerative Therapy and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 109: Africa 16-Year Perspective for Allogeneic Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Therapy and Drug Discovery & Development for the Years 2014, 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biosolution Co. Ltd.
- Cynata Therapeutics Ltd.
- JCR Pharmaceuticals Co. Ltd.
- Lineage Cell Therapeutics Inc.
- MEDIPOST Co. Ltd.
- MiMedx Group Inc.
- Osiris Therapeutics Inc.
- Stempeutics Research Pvt. Ltd.
- Takeda Pharmaceutical Co. Ltd.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | November 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 1.2 Billion |
Forecasted Market Value ( USD | $ 2.4 Billion |
Compound Annual Growth Rate | 10.9% |
Regions Covered | Global |